REPORTS

Let’s Pullulate and Expand Your Business

Communicable Diseases Drugs Market - Global Professional Analysis and Forecast to 2026

Apr 02, 2020  |  146 PAGES  |  REPORT CODE: CMM275070
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Communicable Diseases Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.

This report presents the market size and development trends by detailing the Communicable Diseases Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Communicable Diseases Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Communicable Diseases Drugs industry and will help you to build a panoramic view of the industrial development.

Communicable Diseases Drugs Market, By Type:

  • HIV

  • Influenza

  • TB

  • Malaria

  • Hepatitis

  • HPV

Communicable Diseases Drugs Market, By Application:

  • Hospital

  • Clinic

  • Other

Some of the leading players are as follows:

  • Gilead

  • GSK

  • Merck

  • Boehringer Ingelheim

  • Roche

  • BioCryst Pharmaceuticals

  • Janssen Pharmaceutical

  • Novartis

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Communicable Diseases Drugs Market: Technology Type Analysis

  • 4.1 Communicable Diseases Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Communicable Diseases Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 HIV

    • 4.3.2 Influenza

    • 4.3.3 TB

    • 4.3.4 Malaria

    • 4.3.5 Hepatitis

    • 4.3.6 HPV

5 Communicable Diseases Drugs Market: Product Analysis

  • 5.1 Communicable Diseases Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Communicable Diseases Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Communicable Diseases Drugs Market: Application Analysis

  • 6.1 Communicable Diseases Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Communicable Diseases Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Clinic

    • 6.3.3 Other

7 Communicable Diseases Drugs Market: Regional Analysis

  • 7.1 Communicable Diseases Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Communicable Diseases Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Gilead

    • 9.1.1 Gilead Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 GSK

    • 9.2.1 GSK Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Merck

    • 9.3.1 Merck Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Boehringer Ingelheim

    • 9.4.1 Boehringer Ingelheim Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Roche

    • 9.5.1 Roche Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 BioCryst Pharmaceuticals

    • 9.6.1 BioCryst Pharmaceuticals Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Janssen Pharmaceutical

    • 9.7.1 Janssen Pharmaceutical Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Novartis

    • 9.8.1 Novartis Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

 

The List of Tables and Figures (Totals 68 Figures and 138 Tables)

  • Figure HIV Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure Influenza Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure TB Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure Malaria Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure Hepatitis Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure HPV Communicable Diseases Drugs market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Communicable Diseases Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Communicable Diseases Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Communicable Diseases Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Communicable Diseases Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Communicable Diseases Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Communicable Diseases Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Communicable Diseases Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Communicable Diseases Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Gilead Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioCryst Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top